Proscia
<UNKNOWN>, US · Founded 2014 · Delaware corporation · 12 known investors
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams. The platform enables clinical laboratories and life sciences organizations to improve workflow efficiency, support remote collaboration, and integrate artificial intelligence tools for quantitative tissue analysis and biomarker detection.
Founders & leadership
TL
Tom LoftusDirector
RE
Robert EpsteinDirector
DW
David West, Sr.Executive Officer, Director
DW
David West, Jr.Executive Officer, Director
AN
Alex NiehenkeDirector
Investors · 12
Alpha Intelligence CapitalSan Francisco
Emerald Development ManagersNew York
Flybridge Capital PartnersNew York · $250K – $10M
FusionPalo Alto · $500K – $1M
Green Park & Golf VenturesDallas · $500K – $2M
Hitachi VenturesMunich
Maryland TEDCOUpper Marlboro · $500K – $1.5M
Razor's Edge VenturesReston · $2M – $4M
Robin Hood VenturesPhiladelphia · $250K – $1Mvia Pitou Devgon · inferred
Insight PartnersreportedNew York · $120M – $350M
Scale Venture PartnersreportedBay Area · $5M – $25Mvia Alexander Niehenke · board
SoGal VenturesreportedNew York · $50K – $500K
Reported raises · per SEC filings
Form D private placements▶$35MraisedMar 2025 · 21 investors · Other TechnologyRule 506(b)
▶$35MraisedMar 2025 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alex NiehenkeDirector
- Tom LoftusDirector
- Robert EpsteinDirector
- David West, Sr.Executive Officer, Director
- David West, Jr.Executive Officer, Director
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedJan 2024 · 9 investors · Other TechnologyRule 506(b)
▶$9MraisedJan 2024 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jacob DoftDirector
- David West, Sr.Executive Officer, Director
- Tom LoftusDirector
- David West, Jr.Executive Officer, Director
- Stavish ColemanDirector
- Neil L. CohenDirector
- Alex NiehenkeDirector
- Offering amount
- $15M
- Amount sold
- $9M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$36.6MraisedJun 2022 · 17 investors · Other TechnologyRule 506(b)
▶$36.6MraisedJun 2022 · 17 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jacob DoftDirector
- Neil L. CohenDirector
- Alexander NiehenkeDirector
- David West, Jr.Executive Officer, Director
- Tom LoftusDirector
- Coleman StavishDirector
- David West, Sr.Executive Officer, Director
- Offering amount
- $50M
- Amount sold
- $36.6M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23MraisedDec 2020 · 18 investors · Other TechnologyRule 506(b)
▶$23MraisedDec 2020 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles M. HazardDirector
- David West, Jr.Executive Officer, Director
- David West, Sr.Director
- Neil L. CohenDirector
- Alexander NiehenkeDirector
- Coleman StavishDirector
- Tom LoftusDirector
- Offering amount
- $23M
- Amount sold
- $23M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.3MraisedOct 2018 · 10 investors · Other TechnologyRule 506(b)
▶$8.3MraisedOct 2018 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Neil L. CohenDirector
- David West, Sr.Director
- David West, Jr.Executive Officer, Director
- Offering amount
- $10M
- Amount sold
- $8.3M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$927.2KraisedMay 2017 · 8 investors · Other TechnologyRule 506(b)
▶$927.2KraisedMay 2017 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David West, Sr.Director
- David West, Jr.Executive Officer, Director
- Neil L. CohenDirector
- Offering amount
- $927.2K
- Amount sold
- $927.2K
- Proceeds to insiders
- $52K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1MofferedMay 2016 · Other TechnologyRule 506(b)
▶$1MofferedMay 2016 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David West, Sr.Director
- David West, Jr.Executive Officer, Director
- Offering amount
- $1M
- Proceeds to insiders
- $52K
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- On track to diagnose 32,000 patients daily, Proscia is shaping the future of precision medicine | Insight Partnersinsightpartners.com · 2026
- Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine - Prosciaproscia.com · 2025
- Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicineglobenewswire.com · 2025
- Proscia Raises $50M in Fundingfinsmes.com · 2025
- Philadelphia Medical Technology Company, Proscia, Raises $37M Series C Round | BioBuzzbiobuzz.io · 2024
- Proscia's $46M Series C propels AI-driven pathology into the mainstream | VentureBeatventurebeat.com · 2024